News & Updates

Show Multimedia Only

Stroke recurrence lower with ezetimibe–atorvastatin combo vs atorvastatin alone

05 Oct 2025

Combination therapy with ezetimibe plus atorvastatin appears to better protect against ischaemic stroke recurrence compared with atorvastatin monotherapy, according to a study.

Stroke recurrence lower with ezetimibe–atorvastatin combo vs atorvastatin alone

05 Oct 2025

Stroke during pregnancy makes subsequent pregnancies high-risk

03 Oct 2025

Women who have had an ischaemic stroke (IS) during a pregnancy face increased risk of complications in subsequent pregnancies, according to a study.

Stroke during pregnancy makes subsequent pregnancies high-risk

03 Oct 2025

Brain fog common in patients with GI disorders

01 Oct 2025

Half of the patients with common gastrointestinal (GI) disorders report experiencing brain fog (BF), reveals a study. BF prevalence is higher in patients on probiotics and those with gastroparesis and irritable bowel syndrome (IBS).

Brain fog common in patients with GI disorders

01 Oct 2025

Implantable neurostimulator for Parkinson’s disease shows sustained benefits

30 Sep 2025 by

In the treatment of Parkinson’s disease (PD), the improvements observed following deep brain stimulation of the subthalamic nucleus using an implantable pulse generator system persisted over a 5-year period, according to long-term data from the INTREPID trial.

Implantable neurostimulator for Parkinson’s disease shows sustained benefits

30 Sep 2025

New HTN guidelines advocate for early Tx

30 Sep 2025 by

The new ACC/AHA* hypertension guidelines reinforce previous recommendations to lower blood pressure (BP) early and aggressively, with a greater emphasis on lifestyle interventions, the link between BP and cognitive function, and pregnancy.

New HTN guidelines advocate for early Tx

30 Sep 2025

Levodopa trial for poststroke recovery misses mark

29 Sep 2025 by

Incorporating levodopa into standardized rehabilitation therapy does not confer meaningful benefits in terms of motor function in patients recovering from stroke, as shown in the ESTREL trial.

Levodopa trial for poststroke recovery misses mark

29 Sep 2025

Semaglutide, dulaglutide help prevent cognitive decline in HF patients

28 Sep 2025 by

Treatment with semaglutide and dulaglutide results in a significantly lower risk of adverse cognitive decline in patients with heart failure (HF), as shown by the results of a retrospective cohort study using real-world data.

Semaglutide, dulaglutide help prevent cognitive decline in HF patients

28 Sep 2025

Shortened apixaban therapy ups bleeding in VTE patients

25 Sep 2025

Patients treated with shortened lead-in apixaban for venous thromboembolism (VTE) show increased bleeding events, and those with bleeding risk factors appear to gain no benefit from taking apixaban 10 mg twice daily, according to a study.

Shortened apixaban therapy ups bleeding in VTE patients

25 Sep 2025

Original New Drug Application Approvals by US FDA (16-31 August 2025)

24 Sep 2025

New drug applications approved by US FDA as of 16-31 August 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 August 2025)

24 Sep 2025

Chronic insomnia promotes faster mental decline, dementia

23 Sep 2025 by

People with chronic insomnia face an accelerated rate of cognitive decline and an increased risk of dementia, as shown in new research.

Chronic insomnia promotes faster mental decline, dementia

23 Sep 2025

News & Updates

Showing Neurology articles

Showing

Specialty:

Stroke recurrence lower with ezetimibe–atorvastatin combo vs atorvastatin alone

Stroke recurrence lower with ezetimibe–atorvastatin combo vs atorvastatin alone

Stroke during pregnancy makes subsequent pregnancies high-risk

Stroke during pregnancy makes subsequent pregnancies high-risk

Brain fog common in patients with GI disorders

Brain fog common in patients with GI disorders

Implantable neurostimulator for Parkinson’s disease shows sustained benefits

Implantable neurostimulator for Parkinson’s disease shows sustained benefits

New HTN guidelines advocate for early Tx

New HTN guidelines advocate for early Tx

Levodopa trial for poststroke recovery misses mark

Levodopa trial for poststroke recovery misses mark

Semaglutide, dulaglutide help prevent cognitive decline in HF patients

Semaglutide, dulaglutide help prevent cognitive decline in HF patients

Shortened apixaban therapy ups bleeding in VTE patients

Shortened apixaban therapy ups bleeding in VTE patients

Original New Drug Application Approvals by US FDA (16-31 August 2025)

Original New Drug Application Approvals by US FDA (16-31 August 2025)

Chronic insomnia promotes faster mental decline, dementia

Chronic insomnia promotes faster mental decline, dementia